Our Services
Medical Information
Helpful Resources
Published on: 2/4/2026
GLP-1 medications like semaglutide can indirectly restore fertility by improving insulin resistance and ovulation, especially in PCOS, which has led to more unplanned pregnancies, and they can make oral birth control less reliable during dose changes or with vomiting. These drugs are not recommended in pregnancy, and most guidance advises stopping them at least 2 months before trying to conceive; if you become pregnant while on a GLP-1, stop the medication and contact your clinician promptly. There are several factors to consider for contraception, timing, and safety; see below for important details that could affect your next steps.
Medications known as GLP-1 receptor agonists (often shortened to GLP-1s)—such as semaglutide (brand names include Ozempic and Wegovy)—have changed how doctors treat type 2 diabetes and obesity. Along with weight loss and improved blood sugar control, a surprising trend has emerged: more unplanned pregnancies among women taking these medications. Social media has nicknamed these pregnancies “Ozempic babies.”
While the phrase is catchy, it can also be confusing or alarming. This article explains what’s really going on, what credible medical research says, and what women should know about fertility, pregnancy, and GLP-1 medications—without hype or fear-mongering.
GLP-1s are medications that mimic a natural hormone in your body called glucagon-like peptide-1. This hormone plays several roles:
Because of these effects, GLP-1 medications are prescribed for:
They are not fertility drugs, and they were never designed to help people get pregnant.
The term “Ozempic babies” refers to unexpected pregnancies that occurred after women started taking GLP-1 medications. Importantly, this does not mean GLP-1s directly cause pregnancy or boost fertility hormones.
Instead, experts believe these pregnancies are happening due to indirect effects, especially in women who previously struggled with irregular cycles or infertility related to weight or insulin resistance.
Credible medical organizations and endocrinology experts suggest several mechanisms by which GLP-1s may restore fertility in some women:
In short: some women may become fertile again without realizing it.
PCOS is one of the most common causes of infertility. It is strongly linked to:
Studies show that GLP-1 medications can improve metabolic health in women with PCOS, which may:
This is likely one of the biggest contributors to the “Ozempic babies” phenomenon.
There is an important—and often overlooked—detail.
Some GLP-1 medications slow digestion so much that oral birth control pills may be absorbed less effectively, especially during dose increases or if nausea and vomiting occur.
What this means in practical terms:
This does not mean birth control fails for everyone on GLP-1s, but it is a real consideration worth discussing with a healthcare provider.
This is where clarity matters most.
Because of this:
Stopping a medication can feel stressful, but doctors weigh the risks and benefits carefully for each individual.
If this happens, try not to panic.
Here’s what experts generally recommend:
Many women who conceived while taking GLP-1s have gone on to have healthy pregnancies—but every case is unique.
Not necessarily.
GLP-1 medications can be highly beneficial for many women, improving:
However, women of reproductive age should:
The key issue is awareness, not avoidance.
Some women report changes after starting GLP-1s, including:
If you notice changes and are unsure what they mean, you might consider doing a free, online symptom check for Medically approved LLM Symptom Checker Chat Bot to better understand what could be happening in your body.
This kind of tool can help you prepare for a more informed conversation with your doctor—but it should never replace professional medical care.
Unexpected fertility changes can bring mixed emotions—relief, excitement, confusion, or concern. That’s normal.
What matters most is:
There is no “right” reaction—only what’s right for you.
You should speak to a doctor right away if you:
A healthcare professional can help you make safe, personalized decisions.
“Ozempic babies” are not the result of miracle fertility drugs or medical myths. They are a reminder that GLP-1 medications can change the body in powerful ways, including restoring fertility in some women.
Key takeaways:
Used thoughtfully and with proper medical oversight, GLP-1 medications can be part of a healthy, empowered approach to women’s health.
If anything feels unclear, concerning, or serious, don’t wait—speak to a doctor. Your health and safety always come first.
(References)
* El-Sayed, T. M., Soliman, M. M., El-Said, S. A., & Al-Qurashi, A. M. (2023). GLP-1 receptor agonists and fertility in women: A narrative review. *Frontiers in Endocrinology*, *14*, 1162608. [PMID: 37303867]
* Al-Khalifa, A., Abu-Alsaud, A., & El-Demerdash, E. (2023). Reproductive effects of glucagon-like peptide-1 receptor agonists. *Molecular and Cellular Endocrinology*, *575*, 111979. [PMID: 37494957]
* Cai, S., Ma, J., Wang, S., Fan, S., & Li, M. (2024). Pregnancy and neonatal outcomes following semaglutide exposure during pregnancy: A systematic review and meta-analysis. *Obesity Reviews*, *25*(2), e13645. [PMID: 38243141]
* Mahesan, V., Lim, K. S., & Lim, W. H. (2023). Glucagon-like peptide-1 receptor agonists in the preconception and gestational periods: A comprehensive review. *Frontiers in Endocrinology*, *14*, 1243105. [PMID: 37720054]
* Wu, J., Yan, Y., Lin, W., Cai, S., Ma, J., & Li, M. (2023). Pregnancy and neonatal outcomes following exposure to liraglutide or dulaglutide: a systematic review of real-world data. *Diabetes Therapy*, *14*(7), 1109-1122. [PMID: 37318898]
We would love to help them too.
For First Time Users
We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.
Was this page helpful?
Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.